Octagon Capital Advisors »

Rapt Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $587k 292k 2.01
2024-06-30 $891k 292k 3.05
2024-03-31 $2.6M 292k 8.98
2023-12-31 $7.3M 292k 24.85